Persly provides an AI health service with medical information, personalized assessments and test result analysis.
Founded in 2025 and based in Seoul, South Korea, Persly develops AI health services for individuals. Its platform draws on pre-validated medical resources to provide health assessments and analyze user-uploaded test results. In October 2025, it raised seed funding from Antler Korea and Korea Tech Incubator through the Accelerator Investment-Driven Tech Incubator Program; financial terms were not disclosed. The funding will support work on a predictive model for cancer recurrence.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in